Genetic variations of NR1I3 and NR2B1 in Asian populations

Sin Chi Chew1, Joanne Siok Liu Lim, Onkar Singh

  • 1Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore, Singapore.

Insights

Genetic variations in NR1I3 and NR2B1 genes, which encode the CAR-RXRα heterodimer, were analyzed in Asian populations. Indians showed distinct genetic distributions compared to Chinese and Malays, informing future pharmacogenetics.

Area of Science:

  • Pharmacogenetics
  • Molecular biology
  • Genomics

Background:

  • Nuclear receptors, particularly the CAR-RXRα heterodimer (NR1I3 and NR2B1), act as xenosensors.
  • This heterodimer regulates genes involved in drug metabolism and disposition.

Purpose of the Study:

  • To investigate the frequency distribution and linkage disequilibrium of NR1I3 and NR2B1 genetic variations.
  • To identify tag-SNPs for future pharmacogenetic studies in diverse Asian populations.

Main Methods:

  • Screening of NR1I3 and NR2B1 genes in 168 healthy Asian subjects (Chinese, Malays, Indians).
  • Identification and analysis of single nucleotide polymorphisms (SNPs) and linkage disequilibrium patterns.
  • In-silico prediction of functional SNPs.

Main Results:

  • 38 SNPs in NR1I3 and 88 SNPs in NR2B1 were identified, with many novel low-frequency variants.
  • Genetic variations were primarily in introns; exons were conserved across ethnic groups.
  • Indians exhibited distinct allele frequency distributions compared to Chinese and Malays.

Conclusions:

  • Significant ethnic differences in NR1I3 and NR2B1 genetic variations were observed among Asian populations.
  • Identified tag-SNPs provide a valuable resource for future pharmacogenetic studies.
  • Understanding these genetic variations is crucial for personalized medicine approaches to drug response.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...